Importance of the Anticodon Sequence in the Aminoacylation of tRNAs by Methionyl-tRNA Synthetase and by Valyl-tRNA Synthetase in an Archaebacterium*

Vaidyanathan Ramesh and Uttam L. RajBhandaryDagger

From the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

Received for publication, September 7, 2000, and in revised form, October 30, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The mode of recognition of tRNAs by aminoacyl-tRNA synthetases and translation factors is largely unknown in archaebacteria. To study this process, we have cloned the wild type initiator tRNA gene from the moderate halophilic archaebacterium Haloferax volcanii and mutants derived from it into a plasmid capable of expressing the tRNA in these cells. Analysis of tRNAs in vivo show that the initiator tRNA is aminoacylated but is not formylated in H. volcanii. This result provides direct support for the notion that protein synthesis in archaebacteria is initiated with methionine and not with formylmethionine. We have analyzed the effect of two different mutations (CAUright-arrowCUA and CAUright-arrowGAC) in the anticodon sequence of the initiator tRNA on its recognition by the aminoacyl-tRNA synthetases in vivo. The CAUright-arrowCUA mutant was not aminoacylated to any significant extent in vivo, suggesting the importance of the anticodon in aminoacylation of tRNA by methionyl-tRNA synthetase. This mutant initiator tRNA can, however, be aminoacylated in vitro by the Escherichia coli glutaminyl-tRNA synthetase, suggesting that the lack of aminoacylation is due to the absence in H. volcanii of a synthetase, which recognizes the mutant tRNA. Archaebacteria lack glutaminyl-tRNA synthetase and utilize a two-step pathway involving glutamyl-tRNA synthetase and glutamine amidotransferase to generate glutaminyl-tRNA. The lack of aminoacylation of the mutant tRNA indicates that this mutant tRNA is not a substrate for the H. volcanii glutamyl-tRNA synthetase. The CAUright-arrowGAC anticodon mutant is most likely aminoacylated with valine in vivo. Thus, the anticodon plays an important role in the recognition of tRNA by at least two of the halobacterial aminoacyl-tRNA synthetases.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The sequence and/or structural determinants in the anticodon and in the acceptor stem of tRNAs play an important role in discrimination among tRNAs by aminoacyl-tRNA synthetases. The crystal structure analysis of several aminoacyl-tRNA synthetase-tRNA complexes from eubacteria and eukarya has provided a substantial amount of information on the molecular details of interactions involving these determinants (1-5). However, little is known either at the biochemical level or at the structural level on interaction between aminoacyl-tRNA synthetases and tRNA in archaea. The results of recent work, spurred by a knowledge of the complete genome sequences of several archaea, have highlighted some interesting and surprising differences between three archaeal aminoacyl-tRNA synthetases and their eubacterial and eukaryal counterparts. First, in contrast to lysyl-tRNA synthetases from eubacteria and eukarya, which in general belong to Class II (5), lysyl-tRNA synthetase from Methanococcus jannaschii belongs to Class I (6, 7). Second, a single polypeptide of M. jannaschii has the activity (8, 9) of both a cysteinyl-tRNA synthetase and prolyl-tRNA synthetase. Third, the M. jannaschii tyrosyl-tRNA synthetase has a truncated C-terminal region and lacks most of the tRNA anticodon binding region seen in tyrosyl-tRNA synthetase from eubacteria and eukarya. This finding has led to the suggestion (10, 11) that the anticodon of the M. jannaschii tyrosine tRNA is less important for aminoacylation compared with the anticodon of tRNATyr from eubacteria and eukarya.

In view of the differences found in the three aminoacyl-tRNA synthetases from M. jannaschii, it is important to study the mode of recognition of tRNAs in general by aminoacyl-tRNA synthetases in these and other archaeal systems. Here, we have studied this process in vivo using the halophilic archaeon Haloferax volcanii. We show that the anticodon sequence in the tRNA plays an important role in the recognition of tRNAs by at least two of the aminoacyl-tRNA synthetases, the methionyl-tRNA synthetase (MetRS)1 and the valyl-tRNA synthetase (ValRS). Our results also show that the initiator tRNA is aminoacylated but is not formylated in H. volcanii. This finding provides direct support for the commonly held notion that protein synthesis in archaebacteria does not require formylation of the initiator tRNA (12-14).


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Strain, Plasmids, and Extracts-- The strain H. volcanii WFD11 and the plasmids pUCsptProM and pWL201 (15, 16) were kindly provided by Drs. John R. Palmer and Charles J. Daniels, Department of Microbiology, The Ohio State University, Columbus, OH. The Escherichia coli strains used in this work are E. coli XL1-blue (recA1 endA1 gyr96 thi-1 hsdR17 supE44 relA1 lac (F' proAB lacIqZDelta M15 Tn10 (Tetr))) and E. coli GM2163 (F- ara-14 leuB6 thi-1 fhuA31 lacY1 tsc-78 galK2 galT22 supE44 hisG4 rpsL136 (Strr) xyl-5 mtl-1 dam14::Tn9 (Camr) dcm-6 mcrB1 hsdR2 (rk- mk+) mcrA). H. volcanii S40 extract was a kind gift of Dr. Mechthild Pohlschröeder, University of Pennsylvania, Philadelphia, PA.

Isolation of H. volcanii Genomic DNA-- H. volcanii WFD11 was grown in a medium containing the following components per liter: 125 g of NaCl, 45 g of MgCl2·6H2O, 10 g of MgSO4·7H2O, 10 g of KCl, 1.34 g of CaCl2·2H2O, 3 g of yeast extract, 5 g of tryptone (17). Cells from a 30-ml culture (grown for 48 h with 4% inoculum at 37 °C with aeration) were harvested and suspended in 9.0 ml of 50 mM Tris-HCl (pH 8.0), 25 mM Na2EDTA by vortexing. Significant lysis was observed during this step, and lysis was taken to completion with the addition of SDS to a final concentration of 1%. The lysate was extracted with an equal volume of phenol (saturated with 100 mM Tris-HCl (pH 8.0)) by gentle mixing (inversions in a cyclo mixer at low rpm for 15 min at room temperature). The aqueous phase was collected and reextracted with phenol once more and then twice with chloroform:isoamylalcohol (24:1). The aqueous phase was collected, and sodium acetate (pH 5.4) was added to a final concentration of 0.3 M followed by addition of chilled ethanol. The genomic DNA was spooled, as it precipitated, onto a sterile glass rod, rinsed with 70% ethanol, air dried, and gently suspended in 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (TE) buffer.

Cloning of the Initiator tRNA Gene-- Based on the sequence of the tRNAiMetlocus provided by Dr. C. J. Daniels, the following primers that contained the sites for XbaI and BamHI (italicized) were designed for polymerase chain reaction amplification of the tRNAiMet gene: HvMiF1, 5'-ACATTCTAGACTGTTTGTTGATTCAGCGGGA-3'; HvMiR1, 5'-CTCGGGATCCGGAGTTGAGGTCGGCAAACCA-3'. The primers (100 pmol each) were used to amplify the tRNAiMet gene using H. volcanii genomic DNA as template under the following conditions: 95 °C/1-min initial denaturation followed by 20 cycles, with each cycle containing the steps 95 °C/1 min, 50 °C/1 min, and 72 °C/1 min. This was followed by incubating the tubes at 72 °C for 5 min. The purified polymerase chain reaction product was digested with XbaI and BamHI and cloned into the plasmid pUCsptProM at these sites to generate pUCsptHvMeti. The mutations in the anticodon of the tRNA (U35A36 and G34C36) were generated using pUCsptHvMeti as template by the Quik Change mutagenesis procedure. The smaller HindIII+EcoRI fragment containing the initiator tRNA gene and its mutants from the pUCsptHvMeti plasmid was subcloned into the shuttle plasmid pWL201 at these sites to generate pWL201HvMeti, pWL201HvMetiU35A36, and pWL201HvMetiG34C36, respectively. All initial cloning was done in E. coli XL-1 blue. After confirming the sequence of the desired wild type and mutant initiator tRNA genes, the respective plasmids were used to transform E. coli GM2163. The plasmid DNA isolated from this strain (lacking adenine methylation) was then used to transform H. volcanii.

Transformation of H. volcanii-- The protocol was adapted from Cline et al. (18). All operations were at room temperature. Cells from a 50-ml culture grown to an A600 nm of ~1.0 (25 h at 37 °C) were harvested and gently suspended in 5 ml of spheroplasting buffer (50 mM Tris-HCl (pH 8.3), 0.8 M NaCl, 30 mM KCl, 15% sucrose, 15% glycerol). To 200 µl of the cell suspension, 20 µl of 0.5 M Na2EDTA (pH 8.0) was added and gently mixed. Plasmid DNA (1 µg) in 20 µl of spheroplasting buffer was added and mixed gently. An equal volume (240 µl) of polyethylene glycol solution (60% polyethylene glycol-600 w/v in spheroplasting buffer) was then added, and the mixture was gently mixed and incubated for 20 min at room temperature. The cells were diluted by adding 9 ml of spheroplast dilution buffer (50 mM Tris-HCl (pH 7.2), 3.4 M NaCl, 175 mM MgSO4, 30 mM KCl, 5 mM CaCl2, 15% sucrose), harvested by centrifugation, and resuspended in 1 ml of a 1:1 mixture of spheroplast dilution buffer and H. volcanii growth medium. The transformants were allowed to recover at 37 °C with mild aeration for 12 h. Appropriate aliquots were mixed with molten top agar (55 °C) and poured onto agar plates. The contents of the plates were as follows: bottom agar (per liter), 50 mmol Tris-HCl (pH 7.2), 180 g of NaCl, 43 g of MgSO4, 2.5 g of KCl, 0.7 g of CaCl2·2H2O, 3 g of yeast extract, 5 g of tryptone, and 15 g of agar; top agar, same as above except for 8 g/liter agar and 4 mg/liter mevinolin. Mevinolin was converted to the sodium salt as described (19). The plates were incubated at 37 °C for 7 days.

Isolation of Total tRNA under Acidic Conditions-- The mevinolin-resistant transformants of H. volcanii were grown in liquid medium in the presence of mevinolin (4 mg/liter) for 3 days. The cells from the 3.0-ml culture were chilled on wet ice. All subsequent steps were carried out in the cold. The cells were harvested, resuspended in 0.3 ml of 0.3 M NaOAc (pH 4.5) and 10 mM Na2EDTA, and subjected to two extractions (1 min each) with equal volumes of phenol equilibrated with the same buffer. Total nucleic acids were recovered from the aqueous phase by mixing with 2.5 volumes of ethanol and centrifugation. The pellet was washed with 70% ethanol and dissolved in 20 µl of 10 mM NaOAc (pH 4.5), 1 mM Na2EDTA.

Detection of tRNAs by Northern Blotting-- tRNA (0.1 A260 unit) was subjected to electrophoresis on acid-urea polyacrylamide gels and electroblotted onto a Nytran-Plus membrane (Schleicher & Schuell) as described (20). The membrane was washed with 4× SET (1× SET: 0.05 M NaCl, 0.03 M Tris-HCl, 2 mM Na2EDTA (pH 8.0) containing 1% SDS), baked at 70 °C for 90 min, and prehybridized at 42 °C in 4× SET containing 250 µg/ml sheared salmon sperm DNA, 1% SDS, and 10× Denhardt's solution (1× Denhardt's solution: 0.02% polyvinylpyrrolidone 40, 0.02% bovine serum albumin, and 0.02% Ficoll). tRNAs were detected by hybridization to 5'-32P labeled oligonucleotide probes complementary to nucleotides 29-47 of the wild type and mutant initiator tRNAs, 26-c5 of H. volcanii tRNAGGASer, and 34-47 of H. volcanii tRNAGACVal (21, 22). Hybridization was performed in the same solution at 42 °C for 12 h. The membrane was washed twice (20 min each) with 3× SET and 0.2% SDS at 42 °C. For detecting the mutant tRNAs, the blot was washed with 0.75× SET, 0.05% SDS at 55 °C for 20 min. This wash eliminated the signal from the probe hybridizing to the wild type initiator tRNAiMet.

Measurement of Rates of Deacylation of Aminoacyl-tRNAs-- Total tRNA was prepared from H. volcanii/pWL201HvMetiG34C36 under acidic conditions as described above. About 2 A260 units of tRNA in 10 µl were treated with 0.2 M Tris-HCl (pH 9.6). Aliquots (1 µl) were withdrawn after 15, 30, 60, 90, 120, and 180 min, mixed with 2 µl of 0.3 M NaOAc (pH 4.5), and snap-frozen on dry ice (23). At the end of all the time points, the volume was made up to 10 µl with 10 mM NaOAc (pH 4.5). For analyzing the deacylation of Met-tRNAiMet, the experimental conditions were the same except that incubation times were shorter: 2.5, 5, 7.5, 10, 15, and 30 min. An aliquot corresponding to 0.08 A260 unit of tRNA from each time point was analyzed by acid-urea polyacrylamide gel electrophoresis, and the tRNAs were detected by Northern blot analysis using appropriate hybridization probes as described above.

Isolation of Total tRNAs-- Total tRNAs were prepared from 900 ml of H. volcanii harboring the pWL201 series of plasmids containing the respective tRNA genes. The cells were grown for 60 h in the presence of 4 mg/liter mevinolin. The cells were harvested, resuspended first in 4.5 ml of 3 M NaOAc (pH 5.4), and then made up to 40 ml with TE buffer. The suspension was extracted with an equal volume of phenol saturated with the same buffer by shaking at room temperature for 20 min. The aqueous phase was collected and mixed with 2.5 volumes of ethanol, and the nucleic acids were recovered by centrifugation. The pellet was washed with 70% ethanol, dried, and resuspended in 12 ml of the TE buffer. High molecular weight nucleic acids were precipitated by adding 3 ml of 5 M NaCl. Total tRNA was recovered from the supernatant by ethanol precipitation. The pellet was washed with 70% ethanol, dried, and resuspended in 15 ml of TE buffer containing 0.1 M NaCl. The tRNAs were further purified by DEAE-cellulose chromatography (24).

In Vitro Aminoacylation and Formylation of tRNA-- Total tRNA (0.6 A260 unit) prepared from H.volcanii/pWL201HvMeti cells as described above was aminoacylated with methionine using E. coli MetRS or was aminoacylated with methionine and subsequently formylated using E. coli methionyl-tRNA formyltransferase (MTF). The reaction mixture was extracted with phenol equilibrated with 10 mM NaOAc (pH 4.5). The tRNA was precipitated and analyzed on acid-urea polyacrylamide gels and detected by Northern blot hybridization. Total tRNA prepared from H.volcanii/pWL201HvMetiU35A36 cells was aminoacylated with glutamine using an S-100 extract prepared from E. coli BL21(DE3)/pET3-glnS, which overproduces E. coli glutaminyl-tRNA synthetase (GlnRS) (a kind gift from Dr. M. Ibba).


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The H. volcanii Initiator tRNA-- In the absence of an archaeal in vitro protein synthesis system that can translate a natural mRNA or in the absence of any genetic analysis involving components of the translational initiation machinery, identification of the initiator tRNAiMet in halobacteria is based on the ability of the tRNA to be aminoacylated with E. coli MetRS and to be formylated by the E. coli MTF and the ability of the fMet-tRNAiMet to initiate protein synthesis in an E. coli cell-free system (24). These were also the criteria used to identify the initiator tRNA species in eukarya such as yeast (25), mammalian cells (26), and fungal mitochondria (27) prior to their establishment as initiator tRNAs in eukaryal in vitro protein synthesis systems. Based on these criteria, the sequence of initiator tRNA and/or the gene for the initiator tRNA is known from the following nine archaea: Archaeoglobus fulgidus (GenBankTM accession number NC000917), Halococcus morrhuae (28), H. volcanii (21), Methanobacterium thermoautotropicum (GenBankTM accession number NC000916), M. jannaschii (GenBankTM accession number NC000909), Pyrococcus abyssi (GenBankTM accession number AL096836), Pyrococcus horikoshii (GenBankTM accession number NC000961), Sulfolobus acidocaldarius (28), and Thermoplasma acidophilum (28).

Plasmid-directed Expression in Vivo of the H. volcanii Initiator tRNA Gene-- To study the effect, in vivo, of mutations in the anticodon sequence of initiator tRNA, we cloned the initiator tRNA gene of H. volcanii in the plasmid pWL201 (15, 16). This shuttle vector contains a bla gene coding for resistance to ampicillin, an ori for maintenance of the plasmid in E. coli, another ori for maintenance of the plasmid in H. volcanii, and a gene coding for a mutant 3-hydroxy-3-methylglutaryl-CoA reductase, which confers resistance of H. volcanii to mevinolin. The expression of the initiator tRNA in the resulting plasmid pWL201HvMeti is driven by the H. volcanii tRNALys promoter. This plasmid was isolated from E. coli XL1-blue strain and used to transform H. volcanii WFD11, and the transformants were selected in the presence of mevinolin. To establish the presence of plasmids in the mevinolin-resistant transformants, an attempt was made to isolate plasmid DNA from these cells. The preparation failed to yield ampicillin-resistant transformants when introduced into the E. coli XL1-blue strain. Plasmid DNA was also not detected in this preparation upon agarose gel electrophoresis and ethidium bromide staining. These results suggest that the mevinolin-resistant transformants of H. volcanii do not contain the plasmids bearing the marker 3-hydroxy-3-methylglutaryl-CoA reductase gene and that the resistance is most likely due to integration of the plasmid by homologous recombination of the mutant 3-hydroxy-3-methylglutaryl-CoA reductase gene with the chromosomal gene. Similar observations were made by Holmes et al. (29), who reported the existence of a restriction barrier between E. coli and H. volcanii. This restriction can be avoided by using DNA lacking the N6-methyl adenosine modification within the GATC sequences. For this purpose, the pWL201HvMeti plasmid was used to transform the dam- E. coli GM2163 strain, which is deficient in the N6-adenine methyl transferase. When H. volcanii cells were transformed with the plasmid isolated from the dam- E. coli strain, the efficiency of transformation improved by at least one order of magnitude. The mevinolin-resistant transformants could be maintained and subcultured repeatedly without loss of the plasmid. The plasmid isolated from these transformants also yielded ampicillin-resistant colonies when introduced into E. coli XL1-blue. Based on these results suggesting the stable maintenance of plasmids containing the wild type initiator tRNA gene in H. volcanii, we generated the constructs containing the U35A36 and G34C36 mutations in the anticodon sequence of the initiator tRNA.

Initiator tRNA Is Not Formylated in H. volcanii-- A feature unique to all initiator tRNAs is the presence of three consecutive G:C base pairs in the anticodon stem (Fig. 1; also see Ref. 14 for a review). Other features unique to eubacterial initiator tRNAs include a mismatch between positions 1 and 72 at the end of the acceptor stem and a R11:Y24 base pair in the D-stem (30). Features unique to the eukaryal initiator tRNAs include a A1:U72 base pair at the end of the acceptor stem and A54 and A60 in the T-loop. The archaeal initiator tRNAs have an A1:U72 base pair at the end of the acceptor stem found in the eukaryal initiator tRNAs and a R11:Y24 base pair in the D-stem found in the eubacterial initiator tRNAs (2, 28).



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Top, schematic diagram of eubacterial and eukaryal initiator tRNAs. The unique features in the eubacterial (left) and eukaryal (right) initiator tRNAs are highlighted by arrows. Bottom, sequence of the H. volcanii initiator tRNA in cloverleaf form. The mutations introduced into the anticodon sequence CAU (boxed) are indicated by arrows emanating from it. Also highlighted (arrows) are features common to archaeal initiator tRNAs.

Initiator tRNA is present predominantly as fMet-tRNAfMet in eubacteria and as Met-tRNAiMet in eukarya. Two of the unique features of eubacterial initiator tRNAs, the 1x72 mismatch and the R11:Y24 base pair, play a role in formylation of the E. coli initiator Met-tRNA by E. coli MTF (31-33). Previous studies showed that extracts of Halobacterium cutirubrum, an extreme halophile, lacks MTF activity. Furthermore, tRNA isolated from [35S]methionine-labeled halobacterial cells contained Met-tRNA but no fMet-tRNA (12). These findings, combined with the more recent finding from the genome sequence of several archaea (GenBankTM accession numbers NC000917, NC000916, NC000909, AL096836, and NC000961) that they lack a protein with homology to eubacterial MTFs, have led to the widespread notion that archaea initiate protein synthesis without formylation of the initiator tRNA. Here, we have investigated directly the in vivo state of the H. volcanii initiator tRNA with a probe specific to this tRNA (Fig. 2). For use as markers, total tRNA isolated from these cells was aminoacylated in vitro with E. coli MetRS (Fig. 2A, lane 2) or aminoacylated with MetRS and subsequently formylated with E. coli MTF (lane 3) and subjected to electrophoresis on the same gel. As for the E. coli initiator tRNAfMet (20), all three forms of the H. volcanii initiator tRNA, the tRNAiMet, the Met-tRNAiMet, and the fMet-tRNAiMet, are separated clearly from one another (Fig. 2A, lanes 1, 2, and 3, respectively). The mobility of H. volcanii initiator tRNA isolated from the cells under acidic conditions (Fig. 2A, lane 5) shows that the tRNAiMet is quantitatively aminoacylated; however, there was no detectable accumulation of any fMet-tRNAiMet species. This result provides direct support to the notion that protein synthesis in halobacteria is initiated with methionine and not with formylmethionine.



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   RNA blot hybridization of tRNA isolated from H. volcanii cells. A, total tRNA isolated from H. volcanii/pWL201 HvMeti under acidic conditions was subjected to acid-urea polyacrylamide gel electrophoresis with or without alkali treatment (lanes 4 and 5) and electroblotted onto a membrane. Lanes 1-3 provide markers of tRNAiMet, Met-tRNAiMet, and fMet-tRNAiMet, respectively (details are given under "Experimental Procedures"). The tRNAiMet was detected using a probe directed against nucleotides 29-47 of the tRNA. B, total tRNA isolated from H. volcanii/pWL201 or pWL201HvMeti under acidic conditions was used with (lanes 1 and 3) or without (lanes 2 and 4) alkali treatment. The tRNAiMet and tRNASer were detected using probes directed against nucleotides 29-47 of tRNAiMet and nucleotides 26-c5 of H. volcanii tRNASer, respectively (21, 22).

Fig. 2B, lane 2 shows that the endogenous H. volcanii initiator tRNA was also not formylated in vivo. Thus, the lack of formylation of the H. volcanii initiator tRNA (Fig. 2A, lane 5) is not due to a substantial overproduction of the initiator tRNA in cells carrying the pWL201HvMeti plasmid overwhelming the limiting amounts of a putative Met-tRNAi formyltransferase activity in H. volcanii. Further evidence for this is also derived from the results of a Northern blot analysis similar to that in Fig. 2B, lanes 2 and 4, which show that the initiator tRNA was overproduced only to the extent of 50% in H. volcanii cells carrying the pWL201HvMeti plasmid over the endogenous initiator tRNA.

The CUA Anticodon Mutant Is Aminoacylated Extremely Poorly in Vivo-- The plasmid pWL201HvMetiU35A36 containing the U35A36 anticodon sequence mutant initiator tRNA gene (tRNAiMet (CUA)) was used to transform H. volcanii. The transformants were analyzed for the expression of tRNA by acid-urea polyacrylamide gel electrophoresis followed by Northern blot analysis using a probe specific to the mutant tRNA. As expected, a band corresponding to the U35A36 mutant tRNAiMet was found only in cells containing the plasmid pWL201HvMetiU35A36 (Fig. 3A, compare lanes 1 and 2 to lanes 3 and 4). However, based on PhosphorImager analysis, only ~8% of the mutant tRNA was aminoacylated in vivo (Fig. 3A, lane 4). In contrast, the serine tRNA, which was used as an internal control, was fully aminoacylated (Fig. 3A, lanes 2 and 4). Thus, a two-nucleotide change in the anticodon sequence of the H. volcanii initiator tRNA results in a tRNA that is aminoacylated extremely poorly. These results suggest that, as in eubacteria and eukarya, the anticodon sequence of a tRNA is important for its aminoacylation by the H. volcanii MetRS. Whether the residual aminoacylation of the mutant tRNA, to the extent of ~8%, is with methionine or another amino acid is not known.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   RNA blot hybridization of tRNAs isolated from H. volcanii carrying the pWL201HvMetiU35A36 plasmid. A, analysis of tRNAs isolated under acidic conditions from H. volcanii pWL201, the empty vector (lanes 1 and 2), and H. volcanii pWL201 HvMetiU35A36 (lanes 3 and 4). B, analysis of the H. volcanii U35A36 mutant initiator tRNA before and after aminoacylation with E. coli GlnRS in vitro. The tRNAs were separated by acid-urea polyacrylamide gel electrophoresis and detected by using probes specific for the H. volcanii U35A36 mutant initiator tRNA and the tRNASer, used as a control. Details are given under "Experimental Procedures."aa, aminoacyl.

In E. coli, the corresponding E. coli U35A36 mutant initiator tRNA is aminoacylated with glutamine by GlnRS (34, 35). To determine whether the U35A36 mutant tRNAiMet expressed in H. volcanii can be aminoacylated with glutamine in vitro, we isolated tRNAs from the cells transformed with the plasmid pWL201HvMetiU35A36. The total tRNA preparation was aminoacylated with glutamine using E. coli GlnRS, and the products were analyzed by acid-urea polyacrylamide gel electrophoresis followed by Northern blot analysis (Fig. 3B). The results show that the U35A36 mutant tRNAiMet can be aminoacylated in vitro by the E. coli GlnRS (Fig. 3B, lanes 2 and 3). Thus, the lack of aminoacylation of the H. volcanii mutant initiator tRNA in vivo is due to the absence of an aminoacyl-tRNA synthetase that recognizes this mutant initiator tRNA.

Archaea lack GlnRS and, like most Gram-positive eubacteria (36), use a two-step pathway to generate Gln-tRNA (21, 37). This pathway (the glutamyl-tRNA synthetase-glutamine amidotransferase pathway) involves aminoacylation of the tRNA with glutamic acid followed by conversion of the glutamic acid on the tRNA to glutamine using the enzyme glutamine amidotransferase (38). The finding that the U35A36 mutant of the H. volcanii initiator tRNA is mostly not aminoacylated in vivo also suggests that the mutant tRNA is a poor substrate for the H. volcanii glutamyl-tRNA synthetase.

The GAC Anticodon Mutant Is Most Likely Aminoacylated with Valine-- A second anticodon mutant initiator tRNA gene (G34C36 mutant) containing the GAC anticodon was constructed, and the resulting plasmid pWL201HvMetiG34C36 was used to transform H. volcanii. Expression of the G34C36 mutant initiator tRNA (tRNAiMet (GAC)) was analyzed by acid-urea Northern blotting using an oligonucleotide probe specific to the mutant tRNA. The G34C36 mutant tRNA was detected only in cells containing the pWL201HvMetiG34C36 plasmid (Fig. 4, compare lanes 1 and 2 to lanes 3 and 4). Approximately 45% of the mutant initiator tRNA was aminoacylated in H. volcanii (Fig. 4, lane 4). The tRNA isolated from the cells was deacylated with 0.25 M Tris-HCl (pH 9.6) for 20 min at 37 °C (23). Whereas the H. volcanii Ser-tRNASer was completely deacylated under these conditions, up to 30% of the H. volcanii G34C36 mutant tRNAiMet was still aminoacylated (Fig. 4, lane 3).



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Chemical deacylation of the aminoacylated form of H. volcanii G34C36 mutant initiator tRNA and Ser-tRNA. The reaction was followed by acid-urea polyacrylamide gel electrophoresis and RNA blot hybridization with the tRNA sequence-specific DNA probes. Details are given under "Experimental Procedures."aa, aminoacyl.

The very slow rate of deacylation of the G34C36 mutant aminoacyl-tRNA suggests that the tRNA is not aminoacylated with methionine or most of the other amino acids in H. volcanii (23, 39, 40). It is known that the nature of the amino acid attached to the tRNA determines the rate of deacylation of the aminoacyl-tRNA, with valine and isoleucine having the slowest rates of deacylation (23, 40). The G34C36 mutant initiator tRNA has the anticodon sequence (GAC) corresponding to that of valine tRNA, and it is known that in eubacteria and eukarya, the anticodon sequence is important for aminoacylation of the tRNA with valine (41). Therefore, it is most likely that the G34C36 mutant initiator tRNA is aminoacylated with valine in H. volcanii. To investigate this further, total tRNA isolated from H. volcanii/pWL201HvMetiG34C36 cells under acidic conditions was subjected to deacylation in 0.2 M Tris-HCl (pH 9.6) at 37 °C. The time course of deacylation of the G34C36 mutant aminoacyl-tRNA was compared with those of the H. volcanii Met-tRNAiMet and Val-tRNA1Val. Deacylation was followed by withdrawing aliquots of the reaction mixture at intervals and analyzing the samples by acid-urea gel electrophoresis followed by Northern blot analysis using probes specific for the endogenous tRNAiMet, tRNA1Val, and the G34C36 mutant tRNAiMet (23). The results are shown in Fig. 5. A plot of the residual aminoacyl-tRNA versus time (Fig. 6), based on the PhosphorImager analysis of pixels in the tRNA and aminoacyl-tRNA bands, shows that the half-lives of deacylation of the aminoacyl-tRNAs are ~7 min (Met-tRNAiMet), ~52 min (Val-tRNA1Val), and ~48 min (the G34C36 mutant aminoacyl- tRNAiMet). The extreme closeness of the half-life of the G34C36 mutant aminoacyl-tRNAiMet to that of Val-tRNAVal indicates that the amino acid attached to the tRNA is not methionine but, most likely, valine. These results suggest that the anticodon sequence of a tRNA is also important for its aminoacylation by the H. volcanii ValRS.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Comparison of rates of chemical deacylation of aminoacylated forms of the G34C36 mutant initiator tRNA (A) and the wild type initiator tRNA (B) as followed by Northern blot analysis with tRNA sequence-specific probes. aa, aminoacyl.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Quantitation of the data in Fig. 5 by PhosphorImager analysis of the pixels in the tRNA and aminoacyl-tRNA bands. Plot of residual aminoacyl-tRNA versus time of incubation. The data for the endogenous Val-tRNAVal (GAC) was obtained from the same filter as used for panel A of Fig. 5 after stripping the probe specific for the G34C36 mutant initiator tRNA and reprobing with an oligonucleotide specific for the H. volcanii tRNAVal. aa, aminoacyl.

Further evidence that the G34C36 mutant initiator tRNA is aminoacylated with valine was obtained by a comparison of the valine and isoleucine acceptor activities of total tRNA isolated from cells expressing the G34C36 mutant initiator tRNA. Fig. 7 shows a time course of aminoacylation of tRNAs with valine (left) and with isoleucine (right) using cell-free extracts of H. volcanii. Total tRNA isolated from cells expressing the G34C36 mutant initiator tRNA shows an increase in valine acceptor activity compared with the endogenous tRNA (Fig. 7, left) but no increase in isoleucine acceptor activity (Fig. 7, right) or in methionine acceptor activity (data not shown). These results highlight the importance of the anticodon in aminoacylation of the tRNA by H. volcanii ValRS. The slower rate of aminoacylation of the G34C36 mutant initiator tRNA with valine compared with the endogenous tRNAVal suggests that, whereas the anticodon sequence is important for aminoacylation of a tRNA by the H. volcanii ValRS, there are other determinants that are also important and that are lacking in the G34C36 mutant initiator tRNA. This result is also consistent with the finding that only ~45% of the G34C36 mutant initiator tRNA is aminoacylated in H. volcanii (Fig. 4, lane 4).



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7.   Time course of aminoacylation with valine (left) and isoleucine (right) of H. volcanii total tRNA isolated from cells carrying the empty vector pWL201 or pWL201HvMetiG34C36. The incubation mixture contained 1 A260 unit of total tRNA and 105 µg of proteins in an H. volcanii S40 extract.

Conclusion-- As a first step toward studying the role of the anticodon sequence in aminoacylation of tRNAs by aminoacyl-tRNA synthetases in an archaebacterium, we have described the expression and analysis in vivo of two anticodon sequence mutants of the H. volcanii initiator tRNA. We show that the anticodon sequence is important for aminoacylation by at least two of the H. volcanii aminoacyl-tRNA synthetases, the MetRS and the ValRS. These results are similar to those for the corresponding eubacterial and eukaryal enzymes. It will be interesting to extend these studies to other anticodon sequence mutants to see whether the relative importance of the anticodon sequence for aminoacylation of a tRNA by the archaeal aminoacyl-tRNA synthetases is generally similar to those of the corresponding eubacterial and eukaryal aminoacyl-tRNA synthetases.


    ACKNOWLEDGEMENTS

We thank Dr. Charles Daniels for the H. volcanii strains and vectors, Dr. Mechthild Pohlschröeder for the H. volcanii S40 extracts, and Drs. Michael Ibba and Dieter Söll for E. coli GlnRS. We thank Annmarie McInnis for patience and care in the preparation of this manuscript.


    FOOTNOTES

* This work was supported by Grant R37GM17151 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 617-253-4702; Fax: 617-252-1556; E-mail: bhandary@mit.edu.

Published, JBC Papers in Press, October 31, 2000, DOI 10.1074/jbc.M008206200


    ABBREVIATIONS

The abbreviations used are: MetRS, methionyl-tRNA synthetase; ValRS, valyl-tRNA synthetase; MTF, methionyl-tRNA formyltransferase; GlnRS, glutaminyl-tRNA synthetase.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES


1. Rould, M. A., Perona, J. J., Söll, D., and Steitz, T. A. (1989) Science 246, 1089-1212
2. Ruff, M., Krishnaswamy, S., Boeglin, M., Poterszman, A., Mitschler, A., Podjarny, A., Rees, B., Thierry, J. C., and Moras, D. (1991) Science 252, 1682-1689[Medline] [Order article via Infotrieve]
3. Biou, V., Yaremchuk, A., Tukalo, M., and Cusack, S. (1994) Science 263, 1404-1410[Medline] [Order article via Infotrieve]
4. Cusack, S., Yaremchuk, A., Krikliviy, I., and Tukalo, M. (1998) Structure 1, 101-108
5. Arnez, J. G., and Moras, D. (1997) Trends Biochem. Sci. 22, 211-216[CrossRef][Medline] [Order article via Infotrieve]
6. Ibba, M., Morgan, S., Curnow, A. W., Pridmore, D. R., Vothknecht, U. C., Gardner, W., Lin, W., Woese, C. R., and Söll, D. (1997) Science 278, 1119-1122[Abstract/Free Full Text]
7. Ibba, M., Losey, H. C., Kawarabayasi, Y., Kikuchi, H., Bunjun, S., and Söll, D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 418-423[Abstract/Free Full Text]
8. Stathopoulos, C., Li, T., Longman, R., Vothknecht, U. C., Becker, H. D., Ibba, M., and Söll, D. (2000) Science 287, 479-482[Abstract/Free Full Text]
9. Lipman, R. S. A., Sowers, K. R., and Hou, Y.-M. (2000) Biochemistry 39, 7792-7798[CrossRef][Medline] [Order article via Infotrieve]
10. Steer, B. A., and Schimmel, P. (1999) J. Biol. Chem. 274, 35601-35606[Abstract/Free Full Text]
11. Steer, B. A., and Schimmel, P. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 13644-13649[Abstract/Free Full Text]
12. White, B. N., and Bayley, S. T. (1972) Biochim. Biophys. Acta 272, 583-587[Medline] [Order article via Infotrieve]
13. Bayley, S. T., and Morton, R. A. (1978) CRC Critical Reviews in Microbiology , pp. 151-205, CRC Press, Inc., Boca Raton, FL
14. RajBhandary, U. L., and Chow, C. M. (1995) in tRNA: Structure, Biosynthesis, and Function (Söll, D. , and RajBhandary, U. L., eds) , pp. 511-528, American Society of Microbiology, Washington, D. C.
15. Lam, W. L., and Doolittle, W. F. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 5478-5482[Abstract]
16. Nieuwlandt, D. T., and Daniels, C. J. (1990) J. Bacteriol. 172, 7104-7110[Medline] [Order article via Infotrieve]
17. Daniels, C. J., McKee, A. H. Z., and Doolittle, W. F. (1984) EMBO J. 3, 745-749
18. Cline, S. W., Lam, W. L., Charlebois, R. L., Schalkwyk, L. C., and Doolittle, W. R. (1989) Can. J. Microbiol. 35, 148-152[Medline] [Order article via Infotrieve]
19. Kita, T., Brown, M. S., and Goldstein, J. L. (1980) J. Clin. Invest. 66, 1094-1106[Medline] [Order article via Infotrieve]
20. Varshney, U., Lee, C. P., and RajBhandary, U. L. (1991) J. Biol. Chem. 266, 24712-24718[Abstract/Free Full Text]
21. Gupta, R. (1984) J. Biol. Chem. 259, 9461-9471[Abstract/Free Full Text]
22. Steinberg, S., Misch, A., and Sprinzl, M. (1993) Nucleic Acids Res. 21, 3011-3015[Medline] [Order article via Infotrieve]
23. Drabkin, H., and RajBhandary, U. L. (1998) Mol. Cell. Biol. 18, 5140-5147[Abstract/Free Full Text]
24. RajBhandary, U. L., and Ghosh, H. P. (1969) J. Biol. Chem. 244, 1104-1113[Abstract/Free Full Text]
25. Housman, D., Jacob-Lorena, M., RajBhandary, U. L., and Lodish, H. F. (1970) Nature 227, 913-918[Medline] [Order article via Infotrieve]
26. Smith, A. E., and Marcker, K. (1970) Nature 226, 607-609[Medline] [Order article via Infotrieve]
27. Heckman, J. E., Hecker, L. I., Schwartzbach, S. D., Barnett, W. E., Baumstark, B., and RajBhandary, U. L. (1978) Cell 1, 183-195
28. Kuchino, Y., Ihara, M., Yabusaki, Y., and Nishimura, S. (1982) Nature 298, 684-685[Medline] [Order article via Infotrieve]
29. Holmes, M. L., Nuttal, S. D., and Dyall-Smith, M. L. (1991) J. Bacteriol. 173, 3807-3813[Medline] [Order article via Infotrieve]
30. RajBhandary, U. L. (1994) J. Bacteriol. 176, 547-552[Medline] [Order article via Infotrieve]
31. Lee, C.-P., Seong, B. L., and RajBhandary, U. L. (1991) J. Biol. Chem. 266, 18012-18017[Abstract/Free Full Text]
32. Ramesh, V., Varshney, U., and RajBhandary, U. L. (1997) RNA (N. Y.) 3, 1220-1232[Abstract]
33. Guillon, J.-M., Meinnel, T., Mechulam, Y., Lazennec, C., Blanquet, S., and Fayat, G. (1992) J. Mol. Biol. 224, 359-367[Medline] [Order article via Infotrieve]
34. Schulman, L. H., and Pelka, H. (1985) Biochemistry 24, 7309-7314[Medline] [Order article via Infotrieve]
35. Varshney, U., and RajBhandary, U. L. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1586-1590[Abstract]
36. Wilcox, M., and Nirenberg, M. W. (1968) Proc. Natl. Acad. Sci. U. S. A. 61, 229-236[Medline] [Order article via Infotrieve]
37. White, B. N., and Bayley, S. T. (1972) Can. J. Biochem. 50, 600-609[Medline] [Order article via Infotrieve]
38. Curnow, A. W., Hong, K., Yuan, R., Kim, S., Martins, O., Winkler, W., Henkin, T. M., and Söll, D. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11819-11826[Abstract/Free Full Text]
39. Li, Y., Holmes, W. B., Appling, D. R., and RajBhandary, U. L. (2000) J. Bacteriol. 182, 2886-2892[Abstract/Free Full Text]
40. Matthaei, J. H., Voigt, H. P., Heller, G., Neth, R., Schoch, G., Kubler, H., Amaelunzeu, G., Sander, G., and Parmeggiani, A. (1966) Cold Spring Harbor Symp. Quant. Biol. 31, 25-38[Medline] [Order article via Infotrieve]
41. Schulman, L.-H., and Pelka, H. (1988) Science 242, 765-768[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.